BioAge Labs (BIOA) financial statements
BioAge Labs reported revenue of $9M in fiscal 2025.
Net income was -$81M.
Free cash flow was -$82M.
The diluted share count rose 2048% over the period (dilution).
Revenue and free cash flow
Fiscal years, $ billions.
Income statement
Fiscal years, from BioAge Labs's 10-K filings with the SEC.
| Fiscal year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | — | $0 | $9M |
| Research and development | $34M | $59M | $74M |
| Selling, general and admin | $15M | $19M | $28M |
| Operating income | -$48M | -$78M | -$93M |
| Interest expense | $8M | $2M | $697,000 |
| Pre-tax income | -$64M | -$71M | -$81M |
| Income tax | $0 | $0 | $0 |
| Net income | -$64M | -$71M | -$81M |
| EPS (diluted) | -$38.17 | -$6.63 | -$2.24 |
| Diluted shares | 2M | 11M | 36M |
| Operating margin | — | — | -1031.5% |
| Net margin | — | — | -896.1% |
Balance sheet
Fiscal years, from BioAge Labs's 10-K filings with the SEC.
| Fiscal year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Cash and short-term investments | $22M | $354M | $281M |
| Receivables | — | $0 | $769,000 |
| Total current assets | $25M | $357M | $287M |
| Property, plant and equipment | $323,000 | $591,000 | $963,000 |
| Total assets | $26M | $358M | $295M |
| Total current liabilities | $58M | $28M | $20M |
| Long-term debt | $8M | $3M | $0 |
| Total liabilities | $67M | $35M | $23M |
| Shareholders' equity | -$173M | $323M | $272M |
| Net debt | -$7M | -$346M | -$186M |
Cash flow
Fiscal years, from BioAge Labs's 10-K filings with the SEC.
| Fiscal year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating cash flow | -$37M | -$52M | -$82M |
| Capital spending | $166,000 | $366,000 | $719,000 |
| Free cash flow | -$38M | -$52M | -$82M |
| Stock-based compensation | $3M | $7M | $12M |
| Net borrowing | $12M | -$6M | -$6M |
| Free cash flow margin | — | — | -915.5% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for BIOA.
Open BIOA in InvestinglyQuestions
What was BioAge Labs's revenue in 2025?
$9M in fiscal 2025, from its 10-K filing.
How much free cash flow does BioAge Labs generate?
-$82M in fiscal 2025 (operating cash flow minus capital spending).
From BioAge Labs's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.